Skip to main content
. 2017 Mar 24;96(12):e6336. doi: 10.1097/MD.0000000000006336

Table 3.

Diagnostic performance of APRI and FIB-4 for significant fibrosis and cirrhosis at cut-off values proposed by the WHO HBV guidelines.

3.3.